Safety and Efficacy of Topical NVC-422 Gel in Impetigo
Clinical trial NCT01367314 · COMPLETED
Trial details
- NCT number
- NCT01367314
- Sponsor
- NovaBay Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2010-05-01
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.